ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Diabetes coverage is improving, but could a shake-up be on the way with Novo’s oral semaglutide?
March 06, 2019Payer pressure has been squeezing diabetes drugs, leading to some major sales difficulties and layoff rounds. As Bernstein analyst Wimal Kapadia observes, things are on the mend in terms of 2019 formulary coverage, but one drug could “disrupt them all.”
Pharma Sources Insight January 2025
